Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On February 6, 2026, Enveric Biosciences, Inc. (the “Company”) filed a prospectus supplement (the “Prospectus Supplement”) to register an addition
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibits 5.1 Legal Opinion of Greenberg Traurig, LLP 23.1 Consent of Greenberg Traurig, LLP (con